Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Many patients find that morning dosing reduces lunch and afternoon snacking because the medication's effect coincides with when they're typically hungriest
02 Draw your BAC water Pull the planned volume (usually 2 mL) into a sterile syringe
Patients with structural heart abnormalities, uncontrolled hypertension, or a history of psychosis require thorough physician evaluation before starting either drug
The dose is gradually increased over several weeks to minimise side effects and allow the body to adjust to the medication
It's important to stay well-hydrated, particularly if you experience vomiting or diarrhoea, as dehydration can worsen how you feel and potentially affect sleep
The conditions that most commonly support eligibility include: Obesity (BMI 30, or 27 with at least one comorbidity such as hypertension, sleep apnea, or cardiovascular disease) Type 2 diabetes or prediabetes Insulin resistance with clinical documentation Metabolic syndrome (clinically diagnosed) Polycystic Metabolic Ovarian Syndrome (PMOS) and related hormonal disorders Non-alcoholic fatty liver disease (NAFLD/MASLD) Perimenopause-related metabolic dysfunction with documented hormonal changes GLP-1 receptor agonists including semaglutide, tirzepatide, and retatrutide are the most commonly used peptides in metabolic care today
US$ 23.75
US$ 22.77
US$ 29.48
US$ 20.94
US$ 29.15
